National transplantation pregnancy registry: Report on outcomes in cyclosporine-treated female kidney transplant recipients with an interval from transplant to pregnancy of greater than five years

被引:44
|
作者
Gaughan, WJ
Moritz, MJ
Radomski, JS
Burke, JF
Armenti, VT
机构
[1] THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,DEPT SURG,DIV NEPHROL,PHILADELPHIA,PA 19107
[2] THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,DEPT MED,DIV NEPHROL,PHILADELPHIA,PA 19107
关键词
pregnancy; renal transplantation; transplant interval; cyclosporine;
D O I
10.1016/S0272-6386(96)90311-X
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Successful renal transplantation enables previously infertile females to conceive and carry a pregnancy, Much of the reported data on posttransplantation pregnancy accrued before the advent of cyclosporine, when steroids and azathioprine were the mainstays of maintenance immunosuppression, One factor affecting pregnancy outcome in kidney recipients is the length of time from transplantation to conception or transplant interval, It has been recommended that patients wait at least 2 years posttransplantation to conceive, as transplant intervals of shorter duration have had less favorable outcomes, Some have suggested that extended transplant intervals (> 5 years) paradoxically result in adverse outcomes. We have extracted data on cyclosporine-treated recipients with transplant intervals longer than 5 years from the National Transplantation Pregnancy Registry, and report 17 pregnancies from 15 recipients (transplant interval, 5.9 +/- 0.9 years), There were 13 live births (76.5%) and four spontaneous abortions (23.5%). The mean gestational age was 37.7 +/- 2.04 weeks and mean birth weight was 2,753 +/- 679 g, Prematurity occurred in 30.8%, low birth weight in 15.4%, very low birth weight in 7.7%, and neonatal complications in 15.4%, There were no maternal or neonatal deaths, The mean serum creatinine before pregnancy was 1.31 mg/dL, and there was no significant change during or after pregnancy, There were no rejections during or up to 3 months postpartum, Graft survival at 2 years was 100%, We conclude that most pregnancy outcomes in cyclosporine-treated recipients with transplant intervals greater than 5 years are favorable for the newborn, recipient, and graft. (C) 1996 by the National Kidney Foundation, Inc.
引用
收藏
页码:266 / 269
页数:4
相关论文
共 6 条
  • [1] Pregnancy Outcomes Related to Mycophenolate Exposure in Female Kidney Transplant Recipients
    King, R. W.
    Baca, M. J.
    Armenti, V. T.
    Kaplan, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 (01) : 151 - 160
  • [2] Pregnancy after organ transplantation: A report from the UK transplant pregnancy registry
    Sibanda, Nokuthaba
    Briggs, J. Douglas
    Davison, John M.
    Johnson, Rachel J.
    Rudge, Chris J.
    TRANSPLANTATION, 2007, 83 (10) : 1301 - 1307
  • [3] Pregnancy outcomes in simultaneous pancreas and kidney transplant recipients: a national French survey study
    Normand, Gabrielle
    Brunner, Flora
    Badet, Lionel
    Buron, Fanny
    Catton, Marielle
    Massardier, Jerome
    Esposito, Laure
    Grimbert, Philippe
    Mourad, Georges
    Serre, Jean E.
    Caillard, Sophie
    Karam, Georges
    Cantarovich, Diego
    Morelon, Emmanuel
    Thaunat, Olivier
    TRANSPLANT INTERNATIONAL, 2017, 30 (09) : 893 - 902
  • [4] Effect of pregnancy on long-term kidney function in renal transplant recipients treated with cyclosporine and with azathioprine
    Fischer, T
    Neumayer, HH
    Fischer, R
    Barenbrock, M
    Schobel, HP
    Lattrell, BC
    Jacobs, VR
    Paepke, S
    von Steinburg, SP
    Schmalfeldt, B
    Schneider, KTM
    Budde, K
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (11) : 2732 - 2739
  • [5] Renal transplantation in elderly patients older than 70 years of age: Results from the scientific registry of transplant recipients
    Rao, Panduranga S.
    Merion, Robert M.
    Ashby, Valarie B.
    Port, Friedrich K.
    Wolfe, Robert A.
    Kayler, Liise K.
    TRANSPLANTATION, 2007, 83 (08) : 1069 - 1074
  • [6] Early conversion from cyclosporine to everolimus following living-donor kidney transplantation: outcomes at 5 years post-transplant in the randomized ZEUS trial
    Sommerer, Claudia
    Budde, Klemens
    Zeier, Martin
    Wuethrich, Rudolf P.
    Reinke, Petra
    Eisenberger, Ute
    Muehlfeld, Anja
    Arns, Wolfgang
    Stahl, Rolf
    Heller, Katharina
    Wolters, Heiner H.
    Suwelack, Barbara
    Klehr, Hans Ulrich
    Hauser, Ingeborg A.
    Stangl, Manfred
    Nadalin, Silvio
    Duerr, Michael
    Porstner, Martina
    May, Christoph
    Wimmer, Peter
    Witzke, Oliver
    Lehner, Frank
    CLINICAL NEPHROLOGY, 2016, 85 (04) : 215 - 225